Overview

Infliximab (Remicade) for Patients With Acute Kawasaki Disease

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
This study evaluates the safety of infliximab in infants and children with acute Kawasaki Disease.
Phase:
Phase 1
Details
Lead Sponsor:
University of California, San Diego
Collaborator:
Centocor, Inc.
Treatments:
Antibodies
gamma-Globulins
Immunoglobulins
Immunoglobulins, Intravenous
Infliximab
Rho(D) Immune Globulin